EVs decreased TNF-α, IL-1β, IL-6 and MCP-1 levels in LPS-induced inflammation in mouse macrophage cells (RAW264.7), increased IL-22 levels and decreased hepatic bacterial translocation by reinforcing the intestinal barrier function in alcohol-associated liver disease in mice. Here, CCL2 is linked to liver disorder.